Product/Composition:- | Azithromycin Tablets and Capsules |
---|---|
Strength:- | 250 mg, 500 mg, 600 mg |
Form:- | Oral Tablets and Capsules |
Reference Brands:- | Zithromax, Z-Pak(US); Zidimax(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation. It effectively treats respiratory, skin, and STDs. Benefits include rapid, broad-spectrum activity, tissue penetration, a convenient once-daily regimen, and a favorable safety profile, making it ideal for outpatient and travel-related infections.
Azithromycin tablets and capsules are approved in the EU and US for treating respiratory, skin, and sexually transmitted bacterial infections. In the EU, brands like Zithromax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for azithromycin formulations, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.